Indivior Pharmaceuticals Inc
INDV
Peringkat dalam Saham
#3876
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Harga Saham
$34.01
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$4.24B
Perubahan (1 hari)
4.81%
Perubahan (1 tahun)
40.02%
Negara
US
Perdagangan Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
Rasio P/S untuk Indivior Pharmaceuticals Inc (INDV)
Rasio P/S per October 2026 TTM: 3.20
Menurut laporan keuangan dan harga saham terbaru dari Indivior Pharmaceuticals Inc, rasio P/S saat ini (TTM) adalah 3.20. Pada akhir 2023, rasio P/S perusahaan adalah 1.94.
Riwayat rasio P/S untuk Indivior Pharmaceuticals Inc dari 2016 hingga 2026
Rasio P/S pada akhir setiap tahun
| Tahun | Rasio P/S | Mengubah |
|---|---|---|
| 2026 (TTM) | 3.20 | 131.87% |
| 2024 | 1.38 | -28.93% |
| 2023 | 1.94 | -43.14% |
| 2022 | 3.42 | 5.76% |
| 2021 | 3.23 | 106.90% |
| 2020 | 1.56 | 235.34% |
| 2019 | 0.47 | -54.45% |
| 2018 | 1.02 | -70.40% |
| 2017 | 3.45 | 30.98% |
| 2016 | 2.64 | 0.00% |
Rasio P/S untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/S | Perbedaan Rasio P/S | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 120.57% |
IN
|
